PUBLICATIONS - New from Clinica Reports - Strategies in E-Supply Chain Management
This article was originally published in Clinica
Executive Summary
Executive summary The internet has provided untold opportunities in terms of communications and immediacy, and is changing the traditional supply chain model in the medical device and diagnostics (MD&D) industry. However, it also poses a great number of questions for established businesses and entrepreneurs. For example: * Is it really necessary to go online at all? * Whose technology is best? * What if other members of the supply chain are not online? * How can I secure the transaction? * What are the legal and regulatory implications in terms of international business? Should I join an alliance/e-market? * Do my supply chain management (SCM) staff have the necessary skills? * How can I optimise the business infrastructure? * What are the implications for the way we work? * How can I develop a sharing culture?
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.